Sponsor Pipeline

Beijing Continent Pharmaceutical Co, Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
9
Active Trials
6
Recruiting
4
Phase 3
1
Disease Areas
18
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-14 NCT07364448
A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis
Trial completed
2026-08-14 NCT07364448
A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis
Enrollment increased: 200 -> 411 participants
2026-08-14 NCT07364448
A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis
date change Primary completion moved earlier: 2026-07-30 -> 2026-06-22
2026-08-14 NCT07364448
A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis
date change Completion moved earlier: 2026-08-30 -> 2026-06-22
2026-08-14 NCT07343778
A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic…
Trial completed
2026-08-14 NCT07343778
A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic…
Enrollment increased: 300 -> 337 participants
2026-08-14 NCT07343778
A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic…
date change Primary completion moved earlier: 2026-10-30 -> 2026-07-28
2026-08-14 NCT07343778
A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic…
date change Completion moved earlier: 2026-10-30 -> 2026-07-28
2026-08-14 NCT07417553
A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver…
Trial completed
2026-08-14 NCT07417553
A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver…
Enrollment reduced: 150 -> 67 participants
2026-08-14 NCT07394309
Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy…
Completed without a posted recruiting period
2026-08-14 NCT07394309
Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy…
date change Primary completion pushed: 2026-02-15 -> 2026-05-11
2026-08-14 NCT07394309
Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy…
date change Completion moved earlier: 2026-10-30 -> 2026-05-11
2026-08-14 NCT07262333
A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal…
date change Primary completion pushed: 2026-07-01 -> 2026-12-01
2026-08-14 NCT07262333
A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal…
date change Completion pushed: 2026-07-01 -> 2026-12-01
2026-08-14 NCT07295873
Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil…
Completed without a posted recruiting period
2026-08-14 NCT07295873
Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil…
date change Primary completion moved earlier: 2026-06-30 -> 2026-05-29
2026-08-14 NCT07295873
Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil…
date change Completion moved earlier: 2026-06-30 -> 2026-05-29
Active Trials by Phase
Phase 3
3
Phase 2/3
1
Phase 2
1
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05905172 Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B… Liver Fibrosis Recruiting
NCT05288179 Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis Pneumoconiosis Recruiting
NCT07412236 A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules… Liver Fibrosis Not Yet Recruiting
Phase 2/3
NCT07388680 Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without… Radiation-induced Lung Injury Recruiting
Phase 2
NCT05689645 F573 for Injection for the Treatment of Liver Injury/Failure Acute Liver Failure Recruiting
Phase 1
NCT06899815 Preliminary Human Trials of F230 Tablets Pulmonary Hypertension Recruiting
NCT07262333 A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal… Renal Insufficiency Chronic Recruiting
NCT07262346 The Phase Ⅰd Clinical Trial of Hydronidone Capsules Liver Fibrosis Not Yet Recruiting
NCT07471217 [¹⁴C] Hydronidone Mass Balance Study Chronic Hepatitis B-related Liver Fibrosis Not Yet Recruiting
Disease Areas
Get alerts when Beijing Continent Pharmaceutical Co, Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free